Loading...
In 2000, Intuitive Surgical received FDA clearance for its da Vinci Surgical System — a $1.5 million robot that let surgeons operate through small incisions using joystick-controlled arms. The early evidence for certain procedures like radical prostatectomy was genuinely promising: less blood loss, shorter hospital stays. But what happened next had little to do with evidence. By 2007, a handful of prestigious hospitals — Johns Hopkins, Mayo Clinic, Cedars-Sinai — had installed da Vinci systems. Regional hospitals noticed. CEOs at community hospitals began hearing from their boards: 'Memorial across town just got one. Why don't we?' Surgeons returning from conferences buzzed about it. Patients who'd read a magazine article in a waiting room started asking for 'the robot surgery.' Referra...
Popular framing: Hospitals were duped into buying expensive robots by clever marketing.
Structural analysis: Once prestige hospitals installed da Vinci systems, mimetic desire propagated through the network: community hospital boards measured themselves against peers, patients asked for the device they'd read about, surgeons feared career obsolescence without the training. Social-proof cascades and signaling (state-of-the-art marketing) decoupled adoption from outcome data, while sunk-cost reasoning on $1.5M machines and principal-agent gaps between administrator incentives and patient outcomes locked the cycle in. The prestige object's value became partly clinical, largely mimetic — a system property of how medical technology diffuses through a status-sensitive network.
The popular framing locates the problem in individual decisions (overuse, poor indication selection) and implies it can be fixed with better guidelines or cost controls. The structural analysis reveals that the purchasing cascade was never primarily a medical decision — it was a competitive signaling game played by hospital executives, and evidence was never the operative variable. This matters because the same dynamics are already reproducing with AI-assisted surgery, proton beam centers, and other capital-intensive technologies: each new arms race looks locally rational to every participant while being collectively irrational as a system.
